Carna Biosciences, Inc. (TYO:4572)
Japan · Delayed Price · Currency is JPY 304.00
-2.00 (-0.65%)
Aug 6, 2026, 1:55 PM JST
Carna Biosciences Market Cap
Carna Biosciences has a market cap or net worth of 6.32 billion as of August 5, 2026. Its market cap has increased by 5.67% in one year.
Market Cap
6.32B
Enterprise Value
7.03B
Revenue
619.35M
Ranking
n/a
PE Ratio
n/a
Stock Price
304.00
ChartMarket Cap Chart
Since March 25, 2008, Carna Biosciences's market cap has increased from 4.63B to 6.32B, an increase of 36.51%. That is a compound annual growth rate of 1.71%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 6, 2026 | 6.32B | -7.30% |
| Dec 30, 2025 | 6.81B | 18.93% |
| Dec 30, 2024 | 5.73B | -35.99% |
| Dec 29, 2023 | 8.95B | 21.11% |
| Dec 30, 2022 | 7.39B | -49.61% |
| Dec 30, 2021 | 14.67B | -2.43% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| StemCell Institute | 7.42B |
| Kidswell Bio | 7.20B |
| MEDINET | 7.04B |
| ADR Biomedical Holdings | 7.03B |
| BrightPath Biotherapeutics | 6.81B |
| Chordia Therapeutics | 6.10B |
| CellSource | 6.09B |
| Noile-Immune Biotech | 5.99B |